Alliance Pharma PLC (LSE:APH)
£ 0.465 0.036 (8.39%) Market Cap: 251.36 Mil Enterprise Value: 337.88 Mil PE Ratio: 0 PB Ratio: 1.19 GF Score: 75/100

Full Year 2019 Alliance Pharma PLC Earnings Call Transcript

Apr 07, 2020 / 09:00AM GMT
Release Date Price: £0.694 (+11.94%)
Operator

Hello, everyone, and welcome to the Alliance Pharma Results Call. (Operator Instructions) And just to remind you, this conference call is being recorded.

Today, I am pleased to present Pete Butterfield, CEO; and Andrew Franklin, CFO. I will now hand you over to Pete Butterfield. Please go ahead with your meeting.

Peter Jonathan Butterfield
Alliance Pharma plc - CEO & Executive Director

Thank you very much, and good morning, everybody, and thank you for attending this analyst meeting, which obviously is taking place as a conference call as a result of COVID-19. Firstly, I'd just like to say, I hope your families are all keeping safe and well, and that your businesses are navigating away through this current situation, which is unprecedented for us all. Before we start, please better check that you've got a copy of the presentation in front of you. If not, you can find it on the Investors section of the Alliance website.

So turning to Page 3. Just in terms of what we're going to cover this morning. Clearly want to run through business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot